These results contrast with previous findings in ALS and other neurodegenerative disorders, highlighting the need for further investigation into the biological matrices, temporal dynamics, and disease-specific factors that modulate Cf-mtDNA levels. The gene discussed is CFTR; the disease is amyotrophic lateral sclerosis.